Inside Astellas’ $3B Audentes gene therapy acquisition: coded messages, a bidding war and $77M for the CEO

Word of Astellas’ first multibillion-dollar offer was passed in coded language at a palm tree-lined Park Hyatt in San Diego, where one of gene therapy’s biggest summits was about to begin. Claudia Mitchell had been to the annual Meeting on the Mesa before. Her presentation there as CEO of Universal

Read the full article here

Related Articles